Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Netherlands
Levend verzwakt varicellavirusvaccin, stam oka geproduceerd in humaan diploïde cellijn mrc5

CBG-MEB 2024

Levend verzwakt varicellavirusvaccin, stam oka geproduceerd in humaan diploïde cellijn mrc5

PROVARIVAX, poeder en oplosmiddel voor suspensie voor injectie in een voorgevulde spuit

Poeder en oplosmiddel voor suspensie voor injectieNetherlandsAuthorisedAuthorised 12 Dec 2024

Product informationAsk Osler about it

On this page

Documents
Sources and licences

Documents

The official texts, at the regulator.

Summary of product characteristicsCBG-MEB
Package leafletCBG-MEB
Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removal

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Corrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Levend verzwakt varicellavirusvaccin, stam oka geproduceerd in humaan diploïde cellijn mrc5
Dosage form: Poeder en oplosmiddel voor suspensie voor injectie
Route: Subcutaan gebruik, Intramusculair gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 12 Dec 2024
Registration: 133200//29215
Marketing authorisation holder: Medcor Pharmaceuticals B.V.
ATC code: J07BK01
Group: Anti-infectives for systemic use
Procedure: National (RVG)
Supply: Uitsluitend recept